Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Update

Sunshine Biopharma, Inc. (NASDAQ:SBFM) was the target of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 234,100 shares, a decline of 37.4% from the October 31st total of 374,100 shares. Based on an average trading volume of 612,800 shares, the days-to-cover ratio is presently 0.4 days. Approximately 11.7% of the company’s shares are sold short.

Sunshine Biopharma Stock Performance

Shares of NASDAQ:SBFM traded up $0.13 during mid-day trading on Friday, hitting $2.86. The stock had a trading volume of 143,377 shares, compared to its average volume of 254,091. The company’s 50 day moving average is $2.84 and its 200-day moving average is $1.83. Sunshine Biopharma has a 12-month low of $2.11 and a 12-month high of $608.00. The company has a market cap of $3.50 million, a PE ratio of -0.02 and a beta of 1.38.

Sunshine Biopharma (NASDAQ:SBFM) last released its earnings results on Tuesday, November 5th. The company reported ($0.94) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $9.00 by ($9.94). The business had revenue of $8.44 million during the quarter. Sunshine Biopharma had a negative net margin of 12.82% and a negative return on equity of 17.89%.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.